New Hydrogen Particles Show Promise for Treating Ulcerative Colitis
Regulation of hydrogen and oxidative stress in treating intestinal mucosa from ulcerative colitis
Research hubs: Digestive System · Immune System
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Na Yu, Jingwen Xu, Jie Fan, Huimin Gao, Ting Wu, Yunfeng Zhu, Jing Xu, Xiaolin Li, Huae Xu, Xiaowei Lu
- Journal
- International Journal of Pharmaceutics: X
- Year
- 2025
- DOI
- 10.1016/j.ijpx.2025.100429
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Ulcerative Colitis
- Body System
- Digestive System
This research was done on cells or tissue in a lab, not in people or animals.
TL;DR
A novel MgH₂@MgO hydrogen-releasing particle effectively scavenges ROS, suppresses NF-κB signaling, and alleviates ulcerative colitis, offering a low-toxicity therapeutic strategy for long-term inflammation control.
Key Finding
In mouse models of ulcerative colitis, magnesium hydride particles that release hydrogen effectively reduced harmful reactive oxygen species and suppressed inflammation by blocking the NF-κB signaling pathway.
Summary
Ulcerative colitis is a chronic inflammation of the intestines that causes damage from harmful molecules called reactive oxygen species (ROS). Researchers tested a new particle made of magnesium hydride that releases hydrogen gas in the body. In mouse studies, this particle reduced harmful ROS levels, decreased inflammation, and improved intestinal damage by blocking a specific inflammation pathway called NF-κB.
Practical Takeaway
This is early-stage research in mice only, so results cannot yet be applied to humans with ulcerative colitis. The study suggests hydrogen delivery through this novel particle form may have potential as a future treatment option, but human clinical trials would be needed to determine safety and effectiveness. Anyone with ulcerative colitis should continue working with their healthcare provider rather than self-treating based on this animal research.
Abstract (excerpt)
Ulcerative colitis (UC) is a diffuse chronic inflammation in the superficial intestine. Excessive accumulation of reactive oxygen species (ROS) leads to the of the colorectal damage. As the anti-inflammation therapy needs to be last for at least 3-5 years, the drugs demand less toxicity. However…